Core Laboratories (NYSE:CLB) Upgraded at Wall Street Zen

Wall Street Zen upgraded shares of Core Laboratories (NYSE:CLBFree Report) from a sell rating to a hold rating in a research note issued to investors on Saturday.

Separately, Weiss Ratings downgraded Core Laboratories from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Wednesday, June 24th. One research analyst has rated the stock with a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Reduce”.

Get Our Latest Report on Core Laboratories

Core Laboratories Trading Up 0.9%

Shares of NYSE:CLB opened at $10.73 on Friday. Core Laboratories has a 52-week low of $9.72 and a 52-week high of $20.36. The company has a debt-to-equity ratio of 0.41, a quick ratio of 1.55 and a current ratio of 2.12. The company has a market capitalization of $492.52 million, a P/E ratio of 19.17, a price-to-earnings-growth ratio of 2.57 and a beta of 1.03. The company has a 50-day simple moving average of $11.94 and a 200 day simple moving average of $15.15.

Core Laboratories (NYSE:CLBGet Free Report) last announced its quarterly earnings results on Wednesday, July 29th. The oil and gas company reported $0.11 earnings per share for the quarter, topping analysts’ consensus estimates of $0.09 by $0.02. The firm had revenue of $124.61 million for the quarter, compared to the consensus estimate of $126.26 million. Core Laboratories had a return on equity of 10.03% and a net margin of 5.10%.The business’s revenue was down 4.3% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.19 earnings per share. Core Laboratories has set its Q3 2026 guidance at 0.120-0.200 EPS. Sell-side analysts forecast that Core Laboratories will post 0.53 earnings per share for the current year.

Core Laboratories Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Monday, August 31st. Stockholders of record on Monday, August 10th will be issued a dividend of $0.01 per share. The ex-dividend date of this dividend is Monday, August 10th. This represents a $0.04 dividend on an annualized basis and a dividend yield of 0.4%. Core Laboratories’s dividend payout ratio (DPR) is currently 7.14%.

Institutional Investors Weigh In On Core Laboratories

A number of institutional investors have recently modified their holdings of CLB. Summit Securities Group LLC bought a new stake in Core Laboratories in the 1st quarter valued at about $31,000. Aster Capital Management DIFC Ltd acquired a new position in shares of Core Laboratories during the 4th quarter worth approximately $34,000. CWM LLC increased its holdings in shares of Core Laboratories by 36.1% during the fourth quarter. CWM LLC now owns 2,516 shares of the oil and gas company’s stock worth $40,000 after purchasing an additional 668 shares during the period. Quarry LP increased its holdings in shares of Core Laboratories by 118.1% during the third quarter. Quarry LP now owns 2,953 shares of the oil and gas company’s stock worth $36,000 after purchasing an additional 1,599 shares during the period. Finally, Hantz Financial Services Inc. raised its position in shares of Core Laboratories by 124.7% in the fourth quarter. Hantz Financial Services Inc. now owns 3,177 shares of the oil and gas company’s stock valued at $51,000 after buying an additional 1,763 shares in the last quarter. Institutional investors own 97.81% of the company’s stock.

About Core Laboratories

(Get Free Report)

Core Laboratories N.V. is a global provider of proprietary and patented reservoir description and production enhancement services to the oil and gas industry. The company applies specialized expertise in core and fluid analysis, advanced petrophysical interpretation, and reservoir engineering to optimize hydrocarbon recovery. By integrating laboratory testing with field services and digital analytics, Core Laboratories delivers insights that help operators maximize production and extend the life of their assets.

The company’s portfolio spans two primary service lines: reservoir description and production enhancement.

Recommended Stories

Receive News & Ratings for Core Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.